| Name | Title | Contact Details |
|---|---|---|
Donnette Staas |
Vice President, Regulatory Strategy | Profile |
Caitlin Vaughn |
Director, Compliance | Profile |
Jennifer Green |
Executive Director, Lead Franchise Counsel (Hematology/Oncology) | Profile |
Eric Siegel |
Chief Compliance Officer | Profile |
Eric Siegel |
Chief Compliance Officer | Profile |
Legacy Pharma Inc. is a pharmaceutical company that distributes established prescription pharmaceutical products. We work to ensure that in demand brands remain available for distribution to patients who need them.
Oxford Finance Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA approved treatment. Glycomine develops therapeutics for diseases which have no treatment options.
Triad Life Sciences completes A$25m funding round, anticipates ASX listing in coming months – Learn More >> Triad Life Sciences® introduces InnovaMatrix™Technology Platform, a next-generation extracellular matrix (ECM) product that advance...
Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. We are focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.